# NovaBridge Biosciences (NBP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NBP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -47.38M | $ -1.48M | $ 3.07M | $ 230.94M |
| 2024 | $ 0 | $ 17.25M | $ 0 | $ 3.88M | $ 201.16M |
| 2023 | $ 26.80M | $ -1.58B | $ 0 | $ 133.87M | $ 1.72B |
| 2022 | $ -247.51M | $ -2.80B | $ -2.79B | $ 74.99M | $ 3.01B |
| 2021 | $ 104.63M | $ -2.77B | $ -3.23B | $ 112.46M | $ 4.59B |
| 2020 | $ 1.97B | $ 599.91M | $ 542.12M | $ 13.60M | $ 5.63B |
| 2019 | $ 38.72M | $ -1.92B | $ -1.14B | $ 132.50M | $ -2.03B |
| 2018 | $ 71.03M | $ -532.02M | $ -389.75M | $ 147.03M | $ -955.10M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.13 |
| Current Ratio | 8.09 |

## Other views

- [Metrics](https://sponda.capital/en/NBP.md)
- [Charts](https://sponda.capital/en/NBP/charts.md)
- [Compare](https://sponda.capital/en/NBP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.